RELATE and PREDICT TRD: A pharmacological and neuroimaging study investigating neurobiological effects of Selective Serotonin Reuptake Inhibitors and Norepinephrine Reuptake inhibitors on dopaminergic reward-learning signals and prediction of clinical (non-) response in Major Depressive Disorder.

Trial Profile

RELATE and PREDICT TRD: A pharmacological and neuroimaging study investigating neurobiological effects of Selective Serotonin Reuptake Inhibitors and Norepinephrine Reuptake inhibitors on dopaminergic reward-learning signals and prediction of clinical (non-) response in Major Depressive Disorder.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Mar 2014

At a glance

  • Drugs Escitalopram (Primary) ; Nortriptyline (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms RELATE-TRD
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Mar 2014 Last checked against Netherland Trial register.
    • 28 Jan 2014 New source identified and integrated (European Clinical Trials Database; EudraCT2013-001818-14).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top